Log in

Start free trial
Home 5 Lab Industry Advisor 5 Essential 5 FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests

FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests

by | Apr 14, 2026 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

In both cases, the diagnostic tests report results back within 15 minutes

NG Biotech and MeMed received breakthrough device designation
NG Biotech

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE